Promoting equitable cancer care: learnings from the development of the Optimal Care Pathway for people living in rural and remote areas with cancer
Authors:
- Hannah JongebloedHJHannah Jongebloed
- Rebecca J. BerginRBRebecca J. Bergin
- Helena RodiHRHelena Rodi
- Anna ChapmanACAnna Chapman
- Florian HoneyballFHFlorian Honeyball
- Carmel O'KAneCOCarmel O'KAne
- Megan VarlowMVMegan Varlow
- Kate WhittakerKWKate Whittaker
- Dorothy KeefeDKDorothy Keefe
- Vivienne MilchVMVivienne Milch
- Charlene WrightCWCharlene Wright
- Laura SergeantLSLaura Sergeant
Open Access
- 14 October 2026
- journal article
- Published by Elsevier in eClinicalMedicine
Abstract
No abstract availableFunding Information
- Cancer Council Australia
- Australian Government (MRF2030313)
- Department of Health, Disability and Ageing
- State Government of Victoria
This publication has 9 references indexed in Scilit:
- Principles to guide transdisciplinary health services research informed by a national rural cancer equity programCommunications Health, 2026
- Advancing cancer equity in seven high-income countries: an analysis of policy levers and National Cancer Control PlansThe Lancet Oncology, 2026
- Staff-reported barriers and facilitators to the implementation of healthcare interventions within regional and rural areas: a rapid reviewBMC Health Services Research, 2025
- The changing global landscape of national cancer control plansThe Lancet Oncology, 2024
- Implementing Australia’s first national cancer control plan to shape Australian cancer control policy for the next decade and beyondHolistic Integrative Oncology, 2024
- Setting the policy agenda for cancer control reform: Australia's first national cancer control planMedical Journal of Australia, 2023
- Optimal care pathways: A national policy to improve quality of cancer care and address inequalities in cancer outcomesJournal of Cancer Policy, 2020
- Alignment with Indices of A Care Pathway Is Associated with Improved SurvivaleClinicalMedicine, 2019
- National cancer control plans: a global analysisThe Lancet Oncology, 2018